clinical evaluation on effectiveness and safety of orapenem pediatiric granule for children with bacterial pneumonia

clinical evaluation on effectiveness and safety of orapenem pediatiric granule for children with bacterial pneumonia - KP2

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003765

Enrollment

100

Registered

2011-04-30

Start date

2010-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bacterial penumonia in children

Interventions

orapenem pediatric granule

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: mild to severe bacterial pneumonia by severity classification of guidelines for the management of respiratory infectious diseases in children in Japan 2007

Exclusion criteria

Exclusion criteria: children who refuse or are unable to take medicine children with severe infection who must be treated with parenteral antibiotics

Design outcomes

Primary

Measure	Time frame
effectiveness of orapenem pediatric granule	—

Secondary

Measure	Time frame
safety of orapenem pediatric granule	—

Countries

Japan

Contacts

Public ContactKazunobu Ouchi

Kawasaki Medical School Department of Pediatrics

pediatr@med.kawasaki-m.ac.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026